(TheNewswire)

Tetra Bio-Pharma Inc.
 
 

Montreal – TheNewswire - August 1, 2023 – Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX:TBP) (OTC:TBPMF) (FRA:JAM1) a leader in cannabinoid-derived drug discovery and development announced that it has made a voluntary assignment into bankruptcy under the Bankruptcy and Insolvency Act (Canada). HOULE ROY S.A. (the “Trustee”) has been appointed as Tetra’s trustee in bankruptcy.

On March 7, 2023, the corporation announced that the Ontario Securities Commission rejected an application for a Management Cease Trade Order (MCTO). The rejected MCTO prevented the corporation from negotiating any securities to continue to finance the corporation and blocked Tetra from paying debt with shares. Based on these events the corporation had no other choice but to make a voluntary assignment into bankruptcy.